InvestorsHub Logo

lesgetrich

04/07/17 12:37 PM

#2570 RE: tr1205 #2541

Nice post. It articulates InMed's competitive advantage...

CFN Media Group, one of the leading creative agencies and digital media networks focused on legal cannabis, recently covered InMed Pharma and stated, “InMed Pharma has taken a more precise approach to the drug discovery process than most competitors via its bioinformatics platform. Using extensive databases and proprietary algorithms, the technology rapidly identifies cannabinoid combinations that are likely to have an effect on specific diseases. This helps them dramatically shorten the drug discovery period and increases the likelihood of success from the onset of drug development.


Once they’ve isolated promising cannabinoid compounds, the company isolates the genes responsible for producing them and injects the genes with bacteria that act as a factory for mass producing them in a process similar to the way insulin is manufactured. The company can then combine these various compounds to create unique therapies that target specific diseases without having to worry about costly extraction from entire cannabis plants.”